Silverberg MJ - Search Results

1

Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.

Zalla LC, Cole SR, Eron JJ, Adimora AA, Vines AI, Althoff KN, Silverberg MJ, Horberg MA, Marconi VC, Coburn SB, Lang R, Williams EC, Gill MJ, Gebo KA, Klein M, Sterling TR, Rebeiro PF, Mayor AM, Moore RD, Edwards JK. Zalla LC, et al. Among authors: silverberg mj. JAMA. 2023 Jan 3;329(1):52-62. doi: 10.1001/jama.2022.23617. JAMA. 2023. PMID: 36594946 Free PMC article.

2

Effectiveness of highly-active antiretroviral therapy by race/ethnicity.

Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ; Tri-Service AIDS Clinical Consortium Natural History Study Group. Silverberg MJ, et al. AIDS. 2006 Jul 13;20(11):1531-8. doi: 10.1097/01.aids.0000237369.41617.0f. AIDS. 2006. PMID: 16847408

3

Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy.

Horberg MA, Hurley LB, Silverberg MJ, Kinsman CJ, Quesenberry CP. Horberg MA, et al. Among authors: silverberg mj. J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):531-9. doi: 10.1097/QAI.0b013e318031d7cd. J Acquir Immune Defic Syndr. 2007. PMID: 17224844

4

Older age and the response to and tolerability of antiretroviral therapy.

Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP Jr. Silverberg MJ, et al. Arch Intern Med. 2007 Apr 9;167(7):684-91. doi: 10.1001/archinte.167.7.684. Arch Intern Med. 2007. PMID: 17420427

5

Risk of cancers during interrupted antiretroviral therapy in the SMART study.

Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI. Silverberg MJ, et al. AIDS. 2007 Sep 12;21(14):1957-63. doi: 10.1097/QAD.0b013e3282ed6338. AIDS. 2007. PMID: 17721103 Clinical Trial.

6

AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.

Silverberg MJ, Abrams DI. Silverberg MJ, et al. Curr Opin Oncol. 2007 Sep;19(5):446-51. doi: 10.1097/CCO.0b013e3282c8c90d. Curr Opin Oncol. 2007. PMID: 17762569 Review.

7

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients.

Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, Weinberg WG, Antoniskis D, Mogyoros M, Dodge WT, Dobrinich R, Quesenberry CP, Kovach DA. Horberg MA, et al. Among authors: silverberg mj. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):384-90. doi: 10.1097/QAI.0b013e318160d53e. J Acquir Immune Defic Syndr. 2008. PMID: 18091609

8

Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.

Horberg M, Silverberg M, Hurley L, Delorenze G, Quesenberry C. Horberg M, et al. AIDS Patient Care STDS. 2008 Apr;22(4):301-12. doi: 10.1089/apc.2007.0101. AIDS Patient Care STDS. 2008. PMID: 18338961

9

Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients.

Horberg M, Klein D, Hurley L, Silverberg M, Towner W, Antoniskis D, Kovach D, Mogyoros M, Blake W, Dobrinich R, Dodge W. Horberg M, et al. HIV Clin Trials. 2008 Nov-Dec;9(6):367-74. doi: 10.1310/hct0906-367. HIV Clin Trials. 2008. PMID: 19203902 Clinical Trial.

10

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.

Silverberg MJ, Leyden W, Hurley L, Go AS, Quesenberry CP Jr, Klein D, Horberg MA. Silverberg MJ, et al. Ann Intern Med. 2009 Mar 3;150(5):301-13. doi: 10.7326/0003-4819-150-5-200903030-00006. Ann Intern Med. 2009. PMID: 19258558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page